EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiometabolic multimorbidity and associated clinical, lifestyle and genetic factors among Ghanaian patients

Cyril E. K. Gavor-Kwashi, Oksana Ryabinina, Samuel Badu Nyarko, Naa Aku Addo, Joel Adu Twum, John Anyimadu, Vanessa Naa Torshie Mensah, Ebenezer Allotey Pappoe, Foster Kyei, Ansumana S. Bockarie, Richard Kojo Yankah, Ebenezer Aniakwa-Bonsu und 3 weitere

PLOS One · 17.11.2026 · 21 (11) · e0362848

DOI: 10.1371/journal.pone.0362848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 17.11.2026. Verfasst von Cyril E. K. Gavor-Kwashi und 14 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sam and Brew Butler postgraduate funding from the School of Graduate Studies, Research Support Grant from the Training and Development Section.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiometabolic multimorbidity (coexistence of hypertension, type 2 diabetes, metabolic syndrome and chronic kidney disease) is rising in sub‑Saharan Africa (SSA), but data integrating clinical, lifestyle and genetic determinants in Ghana are limited. This study aimed to characterise the burden of cardiometabolic multimorbidity among Ghanaian clinic attendees and evaluate the associations of clinical, lifestyle, and candidate genetic variants with hypertension, diabetes, metabolic syndrome, and CKD.

Methods

This cross-sectional study assessed 203 adults attending specialised clinics at a tertiary hospital in Cape Coast, Ghana, between 17 May 2023 and 30 April 2024. Data were collected on participants’ sociodemographic and clinicodemographic characteristics, in addition to lifestyle information obtained through structured questionnaires. Selected candidate variants ( TCF7L2 rs7903146, AGT rs699, ACE rs4343, LEPR rs1137101, ADRB3 rs4994, KCNJ11 rs5219, PPARG rs1801282, APOL1 risk variants) were genotyped. Multivariable logistic regression models were used to evaluate the determinants of blood pressure, elevated glucose levels, metabolic syndrome, and CKD. Receiver operating characteristic analysis compared the predictive performance of clinical/lifestyle, genetic, and combined models.

Results

Over 80% of participants had ≥ 2 cardiometabolic conditions; > 80% were overweight/obese, and >2/3 met the metabolic syndrome criteria. Despite high treatment rates, uncontrolled BP and hyperglycaemia were common. Obesity was the strongest independent predictor of CKD (aORs:7–8 for Obese I/II). The use of glucose-lowering medication was associated with better glycaemic control (OR: 7.16, 95% CI: 3.31–15.47, p < 0.001), and antihypertensive treatment was correlated with lower odds of uncontrolled BP (aOR: 0.25, 95% CI: 0.07–0.90, p = 0.033). Among the genetic markers, the TCF7L2 rs7903146 CT genotype was associated with higher odds of hypertension (adjusted odds ratio [aOR]: 2.15, 95% CI: 1.06–4.37, p = 0.034). Most other variants, including APOL1 , showed no consistent associations. Combined clinical, lifestyle, and genetic models had the highest discrimination (AUCs: 0.83–0.89), followed by clinical/lifestyle models (AUCs: 0.76–0.83), while genetic-only models performed poorly (AUCs: 0.63–0.67).

Conclusions

In this Ghanaian cohort, cardiometabolic multimorbidity is highly prevalent and appears to be driven predominantly by modifiable risk factors, particularly obesity. Immediate gains are likely from integrated risk factor management; however, genetic findings are exploratory and require replication in larger, community-based cohorts.

Förderung

  • Sam and Brew Butler postgraduate funding from the School of Graduate Studies
  • Research Support Grant from the Training and Development Section

Zitieren

APA

Gavor-Kwashi, C. E. K., Ryabinina, O., Nyarko, S. B., Addo, N. A., Twum, J. A., Anyimadu, J., Mensah, V. N. T., Pappoe, E. A., Kyei, F., Bockarie, A. S., Yankah, R. K., Aniakwa-Bonsu, E., Ateko, R. O., Blackhurst, D., & Thomford, N. E. (2026). Cardiometabolic multimorbidity and associated clinical, lifestyle and genetic factors among Ghanaian patients. PLOS One, 21(11), e0362848. https://doi.org/10.1371/journal.pone.0362848

Vancouver

Gavor-Kwashi CEK, Ryabinina O, Nyarko SB, Addo NA, Twum JA, Anyimadu J, et al. Cardiometabolic multimorbidity and associated clinical, lifestyle and genetic factors among Ghanaian patients. PLOS One. 2026;21(11):e0362848. doi:10.1371/journal.pone.0362848

BibTeX
@article{GavorKwashi2026,
  author = {Gavor-Kwashi, Cyril E. K. and Ryabinina, Oksana and Nyarko, Samuel Badu and Addo, Naa Aku and Twum, Joel Adu and Anyimadu, John and Mensah, Vanessa Naa Torshie and Pappoe, Ebenezer Allotey and Kyei, Foster and Bockarie, Ansumana S. and Yankah, Richard Kojo and Aniakwa-Bonsu, Ebenezer and Ateko, Richmond Owusu and Blackhurst, Dee and Thomford, Nicholas Ekow},
  title = {Cardiometabolic multimorbidity and associated clinical, lifestyle and genetic factors among Ghanaian patients},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362848},
  doi = {10.1371/journal.pone.0362848}
}
Kostenlos starten →